Connect to other sites within the UBM Medica Network
Masked Hypertension–Cognitive Link Suggests Test
About one-third of US adults have high blood pressure, the leading diagnosis in primary care. Find the latest news about advances in hypertension research in the pages that follow.
Circulatory Disorders Are Primary Care Lifeblood
Hypertension, the “silent killer,” is the leading diagnosis in primary care, and several other circulatory disorders are bringing patients to your practice. Here are the particulars.
ACE Inhibitor Adverse Effects: 3 Questions You Were Afraid to Ask
Like other pharmaceuticals, ACE inhibitors have their own adverse-effect profile. Find quick answers here to clinicians’ FAQs.
A 61-year-old Man with Diabetes and Resistant Hypertension
There are several reasonable options for intensifying this patient's blood pressure treatment. Which one is optimal, though, given his labs and concomitant meds?
Top 10 Primary Care Apps
Drugs, diseases, guidelines, databases—all at the touch of an app. Here: a selection of smartphone/tablet applications that may make your clinical practice a little easier this coming year.
SGLT2 Inhibitor Lowers Blood Pressure Across Medication Classes
In patients taking SGLT2 inhibitors who had treated hypertension, a new study found the drop in blood pressure seen with a diuretic similar to declines seen with other classes of antihypertensive medications.
Empagliflozin Lowered BP in Patients with T2DM and Hypertension
The SGLT2 inhibitor in clinical trials was associated with decreases in systolic blood pressure. The current study looked specifically at the drug's effect on blood pressure--with encouraging results.
By clicking Accept, you agree to become a member of the UBM Medica Community.